Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Amgen Posts Strong Drug Sales, Beats Estimates
Barron's
Wednesday, April 25, 2012 - 10:19am
tags:
Amgen, earnings
Glaxo Plays Hardball With Human Genome Sciences
Investopedia.com
Wednesday, April 25, 2012 - 10:18am
tags:
GSK, Human Genome Sciences, M&A
Lilly sales, profit beat forecasts
Reuters
Wednesday, April 25, 2012 - 10:17am
tags:
earnings, Eli Lilly
Two Hepatitis C Treatments Win U.K. Health-Cost Agency Backing
Bloomberg
Wednesday, April 25, 2012 - 10:17am
tags:
hepatitis C, Victrelis, Merck, UK, JNJ, Incivo
Earnings Preview: Merck Reports Results Friday
Seeking Alpha
Wednesday, April 25, 2012 - 10:16am
tags:
Merck, earnings
Questcor Earnings Seen Again Rising By Triple Digits
Investors.com
Tuesday, April 24, 2012 - 11:21am
tags:
Questcor, earnings
Bristol-Myers Squibb: Earnings Preview
Seeking Alpha
Tuesday, April 24, 2012 - 11:19am
tags:
earnings, Bristol-Myers Squibb
Merck First Quarter Earnings Sneak Peek
Wall St. Cheat Sheet
Tuesday, April 24, 2012 - 10:42am
tags:
Merck, earnings
Watson, Actavis to Merge in €4.5 Billion Deal
WSJ Online
Tuesday, April 24, 2012 - 10:40am
tags:
Watson, Actavis, M&A
Novartis Quarterly Profit Drops as Diovan, OTC Sales Slump
Bloomberg
Tuesday, April 24, 2012 - 10:39am
tags:
Novartis, earnings
Vertex Hopes Two Cystic Fibrosis Drugs Better than One
TheStreet.com
Tuesday, April 24, 2012 - 10:36am
tags:
cystic fibrosis, Vertex, Gilead, Bristol-Myers Squibb, Indenix, Kalydeco, VX-809
Alexion 1Q profit jumps 69 pct on Soliris sales
Yahoo/AP
Tuesday, April 24, 2012 - 10:34am
tags:
Alexion, earnings
ViroPharma denied motion for restraining order, injunction for Vancocin generics
Yahoo/Fly on the Wall
Tuesday, April 24, 2012 - 10:33am
tags:
ViroPharma, generics, Vancocin
NPS Pharmaceuticals: The Next Orphan-Drug Powerhouse?
Seeking Alpha
Tuesday, April 24, 2012 - 10:33am
tags:
orphan drugs, NPS Pharmaceuticals, Gattex, Natpara
Biogen Says Data Highlight Safety Profile For BG-12 MS Drug
FOX Business
Tuesday, April 24, 2012 - 10:27am
tags:
Biogen Idec, BG-12, multiple sclerosis, MS
Illumina Beats on Both Top and Bottom Lines
Motley Fool
Tuesday, April 24, 2012 - 10:11am
tags:
earnings, Illumina
J&J Sticking Together
Investopedia.com
Tuesday, April 24, 2012 - 10:07am
tags:
JNJ, Novartis, Pfizer, Abbott Laboratories, Zimmer, Stryker
Watson in Patent Infringement Lawsuit
Yahoo/Zacks
Tuesday, April 24, 2012 - 10:03am
tags:
patents, Watson Pharmaceuticals, Glumetz, Depomed
Ardea Biosciences: Shareholders Should Tender To AstraZeneca's Bid
Seeking Alpha
Tuesday, April 24, 2012 - 10:01am
tags:
Ardea, AstraZeneca, M&A
Human Genome Most Lucrative on Record Biotech Premiums
Bloomberg
Tuesday, April 24, 2012 - 10:01am
tags:
Human Genome Sciences, GSK, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.